‡ Lipper is an industry research firm whose rankings are based on total return performance, vary over time, and do not reflect the effects of sales charges. Past performance is not indicative of future results.
Putnam Advisor Plus
Putnam Large Cap Value Subaccount
The subaccount seeks capital growth and current income.
Fund description
The subaccount employs Putnam's value strategy, investing primarily in stocks of large companies with underappreciated fundamentals and income potential from growing dividends. The portfolio managers pursue returns for investors across the U.S. equity universe.
Sales story
A multidimensional approach to value investingA relative-value focus The fund focuses on large companies whose stocks are priced below their long-term potential, and where there may be a catalyst for positive change.Dividend growth The fund places a distinct emphasis on companies that can grow their dividends and are able and willing to return cash to shareholders.A disciplined process The portfolio managers invest using fundamental research and quantitative tools supported by strong risk controls in portfolio construction.
Management team
- Darren A. Jaroch, CFA (Investing since 1996)
- Lauren B. DeMore, CFA (Investing since 2002)
Daily pricing as of 09/26/23
| with optional enhanced death benefits | ||
|---|---|---|
| Unit Value | $48.659395 | $47.175495 |
| Unit Value Change | -0.651247 | -0.631586 |
Lipper ranking ‡ as of 08/31/23
Category: Large-Cap Value Funds
| Percentile ranking | Rank/Funds in category | |
|---|---|---|
| 10 yrs. | 13% | 6/49 |
| 1 yr. | 41% | 25/61 |
| 3 yrs. | 22% | 13/60 |
| 5 yrs. | 12% | 7/59 |
Quick facts as of 08/31/23
| Fiscal Year End | December |
| Asset Class | Putnam Advisor Plus |
| Subaccount Status | Open to new investors |
| Number of issues | 70 |
| Turnover (fiscal year end) | 14% |
| Net Assets | $1,608M |
| Inception Date | 05/01/03 |
Performance
Performance as of 06/30/23
| Annualized Performance | Last Quarter | Year to Date |
1 yr. | 3 yrs. | 5 yrs. | 10 yrs. | Life of subaccount |
|---|---|---|---|---|---|---|---|
| Restated performance | |||||||
| Unit Value | 4.86% | 6.26% | 13.68% | 14.98% | 8.97% | 9.15% | 8.28% |
| Standardized | -3.14% | -1.74% | 5.68% | 12.93% | 8.10% | 9.15% | 8.28% |
| With optional enhanced death benefit | |||||||
| Unit Value | 4.82% | 6.18% | 13.51% | 14.81% | 8.80% | 8.98% | 8.11% |
| Standardized | -3.18% | -1.82% | 5.51% | 12.75% | 7.93% | 8.98% | 8.11% |
| Actual performance | |||||||
| Unit Value | 4.86% | 6.26% | 13.68% | 14.98% | 8.97% | 9.15% | 8.28% |
| Standardized | -3.14% | -1.74% | 5.68% | 12.93% | 8.10% | 9.15% | 8.28% |
| With optional enhanced death benefit | |||||||
| Unit Value | -- | -- | -- | -- | -- | -- | -- |
| Standardized | -- | -- | -- | -- | -- | -- | -- |
Annual Performance at NAV
| 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|
| 30.30% | 10.86% | -4.59% | 11.83% | 16.88% | -9.96% | 28.32% | 4.11% | 25.27% | -4.68% |
| With optional enhanced death benefit | |||||||||
| 30.10% | 10.69% | -4.74% | 11.66% | 16.70% | -10.10% | 28.13% | 3.95% | 25.08% | -4.82% |
Restated performance
Monthly as of 08/31/23 |
|
|---|---|
| Unit Value | -2.67% |
| Standardized | -10.45% |
YTD as of 09/26/23 |
|
|---|---|
| Unit Value | 4.06% |
| Standardized | -3.94% |
With optional enhanced death benefit
Monthly as of 08/31/23 |
|
|---|---|
| Unit Value | -2.68% |
| Standardized | -10.47% |
YTD as of 09/26/23 |
|
|---|---|
| Unit Value | 3.95% |
| Standardized | -4.05% |
Unit values and performance information shown apply to the specific annuity product listed, not the underlying Putnam Variable Trust fund. This information should not be used by investors who hold an interest in Putnam Variable Trust funds through a different annuity or other variable product. The unit values and performance of other variable products that offer Putnam Variable Trust funds may be higher or lower due to product charges and expenses or other factors.
Data is historical. Past performance is no guarantee of future results. More recent returns may be less or more than those shown. Investment return and principal value will fluctuate, and you may have a gain or a loss when you sell your units.
Returns shown for the subaccounts for periods before their inception are derived from the historical performance of the underlying fund, adjusted to reflect the mortality, expense risk, and surrender charges applicable to this product and do not factor in the annual $30 contract maintenance fee. Additional riders and options for insurance-related charges will increase expenses and lower returns. Please see the prospectus for details. For a portion of the period, subaccounts may have limited expenses, without which returns would have been lower.
Variable annuities are long-term investments designed for retirement purposes. Putnam Capital Manager products are flexible-premium variable annuities held by Talcott Resolution Life, Inc., Simsbury, CT.
Putnam Everlake variable annuities are flexible-premium deferred variable annuities issued by Everlake Life Insurance Company (Everlake Life); underwritten by Everlake Distributors, L.L.C., both of Northbrook, IL; and sold through registered representatives or bank employees who are licensed insurance agents. Please check for availability in your specific state.
These policies have limitations and are sold by prospectus only. The prospectus contains details on the variable annuity, the subaccounts, contract features, fees, expenses, and other pertinent information.
Investors should carefully consider the investment objectives, risks, charges, and expenses of a fund before investing. For a prospectus containing this and other information for any variable annuity or variable life product that invests in Putnam Variable Trust funds, contact your financial advisor for a contract prospectus and prospectus for the underlying funds. You may also call Talcott Resolution at 1-800-521-0538 or Everlake at 1-800-390-1277. Read the prospectuses carefully before investing.
For the most recent month-end performance, please call Talcott Resolution at 1-800-521-0538 or Everlake at 1-800-390-1277.
Risk Characteristics as of 08/31/23
| Alpha (%) | 3.09 |
| Beta | 0.97 |
| R Squared | 0.99 |
| Standard Deviation (3 yrs.) | 16.76 |
Holdings
| Exxon Mobil Corp | 3.27% |
| Microsoft Corp | 3.22% |
| Oracle Corp | 2.78% |
| Walmart | 2.77% |
| Pultegroup | 2.49% |
| Bank Of America Corp | 2.36% |
| Regeneron Pharmaceuticals | 2.34% |
| Mckesson Corp | 2.06% |
| Goldman Sachs Group The | 1.95% |
| Merck | 1.91% |
| Top 10 holdings, total: | 25.16% |
| Top 10 holdings as of 08/31/23 | |
|---|---|
| 1: Exxon Mobil Corp | 3.27% |
| 2: Microsoft Corp | 3.22% |
| 3: Oracle Corp | 2.78% |
| 4: Walmart | 2.77% |
| 5: Pultegroup | 2.49% |
| 6: Bank Of America Corp | 2.36% |
| 7: Regeneron Pharmaceuticals | 2.34% |
| 8: Mckesson Corp | 2.06% |
| 9: Goldman Sachs Group The | 1.95% |
| 10: Merck | 1.91% |
| Holdings represent 25.16% of portfolio | |
| Top 10 holdings as of 07/31/23 | |
|---|---|
| 1: Microsoft Corp | 3.32% |
| 2: Exxon Mobil Corp | 3.18% |
| 3: Walmart | 2.74% |
| 4: Oracle Corp | 2.70% |
| 5: Bank Of America Corp | 2.61% |
| 6: Pultegroup | 2.58% |
| 7: Qualcomm | 2.18% |
| 8: Goldman Sachs Group The | 2.13% |
| 9: Regeneron Pharmaceuticals | 2.12% |
| 10: Citigroup | 2.10% |
| Holdings represent 25.65% of portfolio | |
| Top 10 holdings as of 06/30/23 | |
|---|---|
| 1: Microsoft Corp | 3.47% |
| 2: Exxon Mobil Corp | 3.28% |
| 3: Oracle Corp | 2.83% |
| 4: Walmart | 2.78% |
| 5: Meta Platforms | 2.53% |
| 6: Pultegroup | 2.45% |
| 7: Bank Of America Corp | 2.42% |
| 8: Mckesson Corp | 2.22% |
| 9: Regeneron Pharmaceuticals | 2.11% |
| 10: Merck | 2.10% |
| Holdings represent 26.20% of portfolio | |
| Top 10 holdings as of 05/31/23 | |
|---|---|
| 1: Meta Platforms | 5.06% |
| 2: Microsoft Corp | 3.56% |
| 3: Exxon Mobil Corp | 3.32% |
| 4: Walmart | 2.76% |
| 5: Oracle Corp | 2.61% |
| 6: Regeneron Pharmaceuticals | 2.30% |
| 7: Pultegroup | 2.21% |
| 8: Bank Of America Corp | 2.21% |
| 9: Mckesson Corp | 2.16% |
| 10: Merck | 2.13% |
| Holdings represent 28.32% of portfolio | |
Portfolio Composition as of 08/31/23
| Common stock | 96.13% |
| Cash and net other assets | 3.87% |
Consider these risks before investing: Value stocks may fail to rebound, and the market may not favor value-style investing. Income provided by the fund may be reduced by changes in the dividend policies of, and the capital resources available at, the companies in which the fund invests. The value of investments in the fundâs portfolio may fall or fail to rise over extended periods of time for a variety of reasons, including general economic, political, or financial market conditions; investor sentiment and market perceptions; government actions; geopolitical events or changes; and factors related to a specific issuer, geography, industry, or sector. These and other factors may lead to increased volatility and reduced liquidity in the fundâs portfolio holdings. Our investment techniques, analyses, and judgments may not produce the outcome we intend. The investments we select for the fund may not perform as well as other securities that we do not select for the fund. We, or the fundâs other service providers, may experience disruptions or operating errors that could have a negative effect on the fund. You can lose money by investing in the fund. Variable annuities are long-term investments designed for retirement purposes. Withdrawals prior to age 59 1/2 may be subject to a 10% IRS penalty.
Sector weightings as of 08/31/23
| Health care | 16.31% |
|---|---|
| Financials | 16.06% |
| Industrials | 10.52% |
| Consumer staples | 9.70% |
| Information technology | 9.36% |
| Energy | 7.95% |
| Materials | 7.81% |
| Consumer discretionary | 6.48% |
| Utilities | 4.98% |
| Other | 10.83% |
0
Expenses
Sales Charges/Fees
| Breakpoint | Sales Charge | Dealer Allowance | CDSC Liab |
|---|---|---|---|
| $0 - $0 | 0.00% | 0.00% | N |
CDSC
| Year | Percent |
|---|---|
| 1 | 8.00% |
| 2 | 8.00% |
| 3 | 8.00% |
| 4 | 7.00% |
| 5 | 6.00% |
| 6 | 5.00% |
| 7 | 4.00% |
| 8 | 3.00% |
| 9+ | 0.00% |